Prospecting natural lignin biodiversity towards unlocking value added bioactive...
Prospecting natural lignin biodiversity towards unlocking value added bioactive motifs and molecules
Global terrestrial plant biodiversity remains a largely untapped source of natural bioactive compounds. In fact, valid sources are even hiding in plain sight, yet not within reach due to lack of effective technical solutions to un...
ver más
31/12/2026
Líder desconocido
3M€
Presupuesto del proyecto: 3M€
Líder del proyecto
Líder desconocido
Fecha límite participación
Sin fecha límite de participación.
Financiación
concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto
el día 2023-11-10
Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.
Información adicional privada
No hay información privada compartida para este proyecto. Habla con el coordinador.
Participantes
Conecta tu I+D
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Información proyecto PROSPLIGN
Duración del proyecto: 37 meses
Fecha Inicio: 2023-11-10
Fecha Fin: 2026-12-31
Líder del proyecto
Líder desconocido
Presupuesto del proyecto
3M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Global terrestrial plant biodiversity remains a largely untapped source of natural bioactive compounds. In fact, valid sources are even hiding in plain sight, yet not within reach due to lack of effective technical solutions to unlock their potential. In this context, the PROSPLIGN consortium has developed an innovative bioprospecting approach that uses cutting-edge and complementary chemical and enzymatic methods, supported by statistical analysis and coupled with high-throughput detection methods, to enable the discovery of bioactive molecules from lignin, one of the fractions of the most abundant biopolymer on Earth (lignocellulose). Lignin chemical biodiversity will enable PROSPLIGN to cover three target markets (pharmaceuticals, cosmetics and fragrances) with a combined market of >€1.4 trillion. The project will use lignin derived from 9 different species and investigate at least 3 different chemical approaches and 10 different enzymes to obtain up to 1000 mixtures of lignin-derived compounds, and then pass a progressively narrower hit validation funnel in industrially relevant environments, being screened via up to 17 different bioactivity assays. Sustainable production routes for at least 2 of the most promising compounds per sector, directly or following derivatisation, will be proposed. Compared to traditional approaches, PROSPLIGN's bioprospecting avoids animal cruelty, expensive exploration efforts (no novel animal/plants discovery), disruptive extractions (seeking hidden gems in an abundant but underexploited biomass mine), and directly targets the liberation of readily testable bio/chemical-functionality present in plant material, superior to other approaches relying on manipulation-intensive microbial strain culture or extrapolation from DNA/RNA). Ultimately, PROSPLIGN will contribute to a new generation of biobased bioactives, unlocking more value from existing sources whose immense potential has yet to be harnessed.